BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates

  Kinnate Biopharma Inc., a clinical-stage precision oncology company, announced financial results for the third quarter of 2023 and recent corporate updates.

  November 9, 2023

   · 

  9 min read
• Business

  Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

  Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported financial results for the third quarter ended September 30, 2023, and provided an update on the continued advancement of its clinical programs.

  November 9, 2023

   · 

  13 min read
• Business

  Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

  Rain Oncology Inc. reported financial results for the third quarter ended September 30, 2023, along with an update on the Company’s key developments and business operations.

  November 9, 2023

   · 

  4 min read
• Business

  Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments

  Barinthus Biotherapeutics plc, formerly Vaccitech plc, announced its financial results for the third quarter of 2023 and provided an overview of its progress.

  November 9, 2023

   · 

  12 min read
• Business

  Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements

  Tarsus Pharmaceuticals, Inc. announced financial results for the third quarter ended September 30, 2023, and recent business achievements.

  November 9, 2023

   · 

  14 min read
• Biotech Beach

  Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers

  Exagen Inc., a leading provider of autoimmune testing solutions, and Johns Hopkins University jointly announced the execution of an exclusive license agreement.

  November 9, 2023

   · 

  3 min read
• Bio NC

  Humacyte Third Quarter 2023 Financial Results and Business Update

  Humacyte, Inc. (Nasdaq: HUMA) today announced financial results for the third quarter ended September 30, 2023 and highlighted recent corporate accomplishments advancing the investigational, universally implantable Human Acellular Vessel (HAV) closer to planned U.S. market launch.

  November 9, 2023

   · 

  15 min read
• Business

  Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

  Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today reported its third quarter operating and financial results and reviewed recent business highlights.

  November 9, 2023

   · 

  9 min read
• Business

  Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results

  Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced results for the quarter ended September 30, 2023.

  November 9, 2023

   · 

  13 min read
• Pharm Country

  Lisata Therapeutics Announces Participation in Upcoming Conferences in November 2023

  Lisata Therapeutics, Inc. announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will present at the following conferences in November.

  November 9, 2023

   · 

  2 min read